We envision a world where no one dies of tuberculosis. However, this cannot be achieved without improved, faster-acting, and affordable tuberculosis drug regimens that are available to all who need them. These new cures can bring renewed health, hope, and prosperity to millions. 

Since our inception in 2000, TB Alliance has led the global search for and development of new TB regimens, catalyzing the field and convening cross-sector partnerships to forge the progress that is urgently needed for better TB treatments.

Health Care

Tobacco

TB Alliance

Mel Spigelman

Nader Fotouhi

Maria Beumont

Majda Benhayoun

Kathleen Schostack

Sandeep Juneja

Colleen Pero

Angela Vanderploeg

Pietro Turilli

The Scientific and Research Team at TB Alliance spearheads the discovery, development, and optimization of new tuberculosis drug regimens. Comprising experts in biology, preclinical and clinical project management, medical affairs, chemistry, and R&D, the team collaborates on innovative approaches to create faster-acting, affordable treatments, ultimately aiming to eliminate deaths from tuberculosis worldwide.

Scientific and Research Team

Leadership Team

Clinical Operations Team

Scientific and Research Team

About

Team members

Other teams at TB Alliance

Leadership Team

Clinical Operations Team